Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Microscopic Colitis, Autoimmune and Inflammatory Disorders, and Immunodeficiency and Autoimmune Disorders.
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease
Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An Update
Rates of Postoperative Recurrence of Crohn’s Disease and Effects of Immunosuppressive and Biologic Therapies
A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of the S1P Receptor Agonist KRP203 in Patients with Moderately Active Refractory Ulcerative Colitis
Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium
Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease
Ustekinumab Exposure-outcome Analysis in Crohn’s Disease Only in Part Explains Limited Endoscopic Remission Rates
Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative Colitis
Prevalence of Anal Fistulas in Europe: Systematic Literature Reviews and Population-Based Database Analysis
Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel Diseases
Mucosal IL13RA2 expression predicts nonresponse to anti‐TNF therapy in Crohn's disease
Outcome of biological therapies in chronic antibiotic‐refractory pouchitis: A retrospective single‐centre experience
Gene and Mirna Regulatory Networks During Different Stages of Crohn’s Disease
Prevalence of Anal Fistulas in Europe: Systematic Literature Reviews and Population-Based Database Analysis.
Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease
Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn’s Disease: A Prospective Multicentre Study
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD Patients
OP37 Efficacy and safety of ustekinumab as maintenance therapy in ulcerative colitis: Week 44 results from UNIFI
New treatment options for inflammatory bowel diseases
Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases
No Change in Determining Crohn’s Disease Recurrence or Need for Endoscopic or Surgical Intervention With Modification of the Rutgeerts’ Scoring System
Prognostic value of histological activity in patients with ulcerative colitis in deep remission: A prospective multicenter study
Influence of early adalimumab serum levels on immunogenicity and long‐term outcome of anti‐TNF naive Crohn's disease patients: the usefulness of rapid testing
Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease
Endoscopic management of Crohn’s strictures
TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn’s disease patients?
Vedolizumab in Refractory Microscopic Colitis: An International Case Series
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease